{
  "Abemaciclib": [
    "Abemaciclib",
    "1231929-97-7",
    "LY2835219",
    "Verzenio",
    "LY-2835219",
    "N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine",
    "Verzenios",
    "60UAB198HK",
    "N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine",
    "LY 2835219",
    "LY2835210",
    "LY-2835210",
    "2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)",
    "5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine",
    "5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl)amine",
    "abemaciclibum",
    "N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo(d)imidazol-6-yl)pyrimidin-2-amine",
    "N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl)pyrimidin-2-amine",
    "N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine",
    "N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl]pyrimidin-2-amine",
    "RefChem:58097",
    "L01XE50",
    "LY2385219",
    "806-670-8",
    "LY2835219 free base",
    "UNII-60UAB198HK",
    "MFCD22665744",
    "2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-",
    "C27H32F2N8",
    "HY-16297A",
    "s5716",
    "CS-1230",
    "N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-1,3-benzodiazol-5-yl)pyrimidin-2-amine",
    "N-{5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]pyrimidin-2-amine",
    "Abemaciclib [USAN:INN]",
    "LY2835219 (free base)",
    "rimidin-2-amine",
    "Verzenio (TN)",
    "6ZV",
    "N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]py rimidin-2-amine",
    "Abemaciclib (Standard)",
    "ABEMACICLIB [MI]",
    "ABEMACICLIB [INN]",
    "ABEMACICLIB [JAN]",
    "ABEMACICLIB [USAN]",
    "ABEMACICLIB [WHO-DD]",
    "Abemaciclib (JAN/USAN/INN)",
    "GTPL7382",
    "orb1305567",
    "SCHEMBL2487229",
    "CHEMBL3301610",
    "SCHEMBL29356350",
    "SCHEMBL29423472",
    "SCHEMBL29591527",
    "ABEMACICLIB [ORANGE BOOK]",
    "DTXSID20673119",
    "EX-A521",
    "LY 2835219 (free base)",
    "CHEBI:233362",
    "UZWDCWONPYILKI-UHFFFAOYSA-N",
    "HMS3673I05",
    "HMS5085C17",
    "HY-16297AR",
    "EX-A1588",
    "BDBM50110183",
    "NSC768073",
    "NSC783671",
    "1231929-97-7, Verzenio,",
    "AKOS025404907",
    "LY2835219 free base (Abemaciclib)",
    "CCG-269750",
    "DB12001",
    "NSC-768073",
    "NSC-783671",
    "SB16476",
    "LY2835219 free base (Abemaciclib)?",
    "NCGC00351599-02",
    "NCGC00351599-06",
    "AC-30666",
    "AS-10230",
    "BP-43621",
    "DA-33422",
    "FE103812",
    "LY2835219 Ms salt, Abemaciclib Ms salt",
    "LY 2835210",
    "NS00072970",
    "D10688",
    "EN300-7406007",
    "F979456",
    "BRD-K33622447-066-01-9",
    "Q23901483",
    "[5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine",
    "Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine",
    "N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine",
    "N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridyl]-5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-benzimidazol-5-yl)pyrimidin-2-amine",
    "N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]py"
  ],
  "Alpelisib": [
    "Alpelisib",
    "alpelisib",
    "1217486-61-7",
    "BYL-719",
    "BYL719",
    "Piqray",
    "NVP-BYL719",
    "Vijoice",
    "BYL 719",
    "08W5N2C97Q",
    "1,2-PYRROLIDINEDICARBOXAMIDE, N1-[4-METHYL-5-[2-(2,2,2-TRIFLUORO-1,1-DIMETHYLETHYL)-4-PYRIDINYL]-2-THIAZOLYL]-, (2S)-",
    "(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide",
    "1,2-Pyrrolidinedicarboxamide, N1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl)-2-thiazolyl)-, (2S)-",
    "DTXSID70153355",
    "(S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl)thiazol-2-yl)amide",
    "alpelisibum",
    "(2S)-1-N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)-1,3-thiazol-2-yl)pyrrolidine-1,2-dicarboxamide",
    "(2S)-1-N-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide",
    "RefChem:57062",
    "DTXCID7075846",
    "L01XX65",
    "Phosphoinositide 3-kinase Inhibitor BYL719",
    "Alpelisib (BYL719)",
    "(S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide",
    "MFCD22417085",
    "UNII-08W5N2C97Q",
    "Alpelisib [USAN:INN]",
    "CHEMBL2396661",
    "Alpelisib [INN]",
    "(2s)-N~1~-{4-Methyl-5-[2-(1,1,1-Trifluoro-2-Methylpropan-2-Yl)pyridin-4-Yl]-1,3-Thiazol-2-Yl}pyrrolidine-1,2-Dicarboxamide",
    "(S)-N1-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide.",
    "C19H22F3N5O2S",
    "4jps",
    "1LT",
    "Alpelisib [USAN]",
    "Vijoice (TN)",
    "Piqray (TN)",
    "ALPELISIB [JAN]",
    "ALPELISIB [MI]",
    "ALPELISIB [WHO-DD]",
    "Alpelisib (JAN/USAN/INN)",
    "GTPL7955",
    "orb1307105",
    "SCHEMBL1911869",
    "ALPELISIB [ORANGE BOOK]",
    "SCHEMBL29358059",
    "CHEBI:93752",
    "EX-A405",
    "STUWGJZDJHPWGZ-LBPRGKRZSA-N",
    "BDBM738244",
    "BYL 719; BYL719",
    "BDBM50436459",
    "NSC765974",
    "NSC800065",
    "s2814",
    "AKOS022186315",
    "CCG-269139",
    "CS-0663",
    "DB12015",
    "FP71607",
    "NSC-765974",
    "NSC-800065",
    "SDCCGSBI-0654479.P001",
    "US20250145589, Example Alpelisib",
    "NCGC00346717-03",
    "NCGC00346717-06",
    "NCGC00346717-12",
    "(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidine",
    "AC-37083",
    "AS-16349",
    "HY-15244",
    "NS00072895",
    "SW220128-1",
    "cas:1217486-61-7;BYL-719",
    "D11011",
    "EN300-23810842",
    "BRD-K54997624-001-06-0",
    "Q27074391",
    "(2S)-N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-4-pyridyl]thiazol-2-yl]pyrrolidine-1,2-dicarboxamide",
    "(2S)-N1-{4-Methyl-5-[1-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide",
    "(2S)-N1-{4-METHYL-5-[2-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)PYRIDIN-4-YL]-1,3-THIAZOL-2-YL}PYRROLIDINE-1,2-DICARBOXAMIDE",
    "(S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl]thiazol-2-yl]amide;A  lpelisib"
  ],
  "Anastrozole": [
    "Anastrozole",
    "anastrozole",
    "120511-73-1",
    "Arimidex",
    "anastrazole",
    "Anastrozol",
    "ZD1033",
    "ICI D1033",
    "ZD-1033",
    "ICI-D1033",
    "ZD 1033",
    "DTXSID9022607",
    "2Z07MYW1AZ",
    "NSC-719344",
    "NSC-759855",
    "CHEBI:2704",
    "alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile",
    "Rvg-106400",
    "NSC719344",
    "DTXCID202607",
    "1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-",
    "Zeneca ZD 1033",
    "2-[3-(1-cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile",
    "anastrozolum",
    "Nastrosa",
    "Anastrozole Tablets",
    "2-(3-(1-Cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl)-2-methylpropanenitrile",
    "2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)",
    "RefChem:54202",
    "L02BG03",
    "2,2'-(5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene)di(2-methylpropionitrile)",
    "Alpha,alpha,alpha', alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile",
    "2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile)",
    "MFCD00866298",
    "CHEMBL1399",
    "2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)",
    "NCGC00164619-01",
    "Asiolex",
    "alpha1,alpha1,alpha3,alpha3-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile",
    "Arimidex (TN)",
    "SMR000466301",
    "CAS-120511-73-1",
    "HSDB 7462",
    "ICI-D 1033",
    "SR-01000759390",
    "UNII-2Z07MYW1AZ",
    "Anastrozole?",
    "2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile",
    "CCRIS 9352",
    "Anastrozole [USAN:USP:INN:BAN]",
    "Anastrozole; 2,2'-[5-(1H-1,2,4-Triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)",
    "Anastrozole (Standard)",
    "Arimidex (AstraZeneca)",
    "ANASTROZOLE [MI]",
    "ANASTROZOLE [INN]",
    "ANASTROZOLE [JAN]",
    "ANASTROZOLE [HSDB]",
    "ANASTROZOLE [USAN]",
    "SCHEMBL9726",
    "ANASTROZOLE [MART.]",
    "ANASTROZOLE [USP-RS]",
    "ANASTROZOLE [WHO-DD]",
    "MLS000759396",
    "MLS001424217",
    "MLS006011961",
    "GTPL5137",
    "orb1310655",
    "Anastrozole (JP18/USP/INN)",
    "Anastrozole - Bio-X trade mark",
    "BDBM10015",
    "ANASTROZOLE [ORANGE BOOK]",
    "ANASTROZOLE [EP MONOGRAPH]",
    "ANASTROZOLE [USP IMPURITY]",
    "GLXC-03925",
    "HMS2052M11",
    "HMS2089N10",
    "HMS2235M06",
    "HMS3369K05",
    "HMS3394M11",
    "HMS3654I18",
    "HMS3715B05",
    "HMS3742O21",
    "HMS3866K03",
    "HMS5079E13",
    "Pharmakon1600-01502278",
    "ANASTROZOLE [USP MONOGRAPH]",
    "ALBB-037397",
    "VEA51232",
    "Tox21_112238",
    "Tox21_303568",
    "HY-14274R",
    "NSC759855",
    "s1188",
    "STL451008",
    "AKOS015894980",
    "tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile",
    "Tox21_112238_1",
    "AC-4234",
    "CCG-101109",
    "CS-0716",
    "DB01217",
    "FT10600",
    "KS-5052",
    "NC00359",
    "NSC 719344",
    "NSC 759855",
    "SB17304",
    "2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)",
    "2-[3-(1-cyano-1-methyl-ethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile",
    "3-Phenylene]bis(2-methyl-propiononitrile",
    "NCGC00164619-02",
    "NCGC00164619-04",
    "NCGC00257356-01",
    "BT164176",
    "HY-14274",
    "A2370",
    "NS00005588",
    "SW197739-4",
    "11A731",
    "C08159",
    "D00960",
    "EN300-118709",
    "AB00639929-06",
    "AB00639929-08",
    "AB00639929-09",
    "AB00639929-10",
    "AB00639929_11",
    "AB00639929_13",
    "A804526",
    "Q419143",
    "2;2\"-[5-(1H-1;2;4-Triazol-1-ylmethyl)-1",
    "SR-01000759390-4",
    "SR-01000759390-5",
    "BRD-K52172416-001-10-6",
    "BRD-K52172416-001-11-4",
    "Z1515385077",
    "1,.alpha.,alpha.,alpha.',.alpha.'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-",
    "2,2'-[5-(1H-1,2,4-triazol-1-yl-methyl)-1,3-phenylene]-di(2-methyl propionitrile)",
    "2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropiononitrile)",
    "2,2'-[5-(1H-1,2,4-triazole-1-yl-methyl)-1,3-phenylene]di(2-methyl propionitrile)",
    "2-[3-(2-cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile",
    "2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile",
    "a,a,a',a'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile",
    ".alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile",
    ".ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.'-TETRAMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-M-BENZENEDIACETONITRILE",
    "1,3-BENZENEDIACETONITRILE,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.'-TETRAMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-",
    "2-[3-(1-cyano-1-methylethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl]-2-methylpropanenitrile",
    "alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile"
  ],
  "Aromatase inhibitor": [
    "Aromatase inhibitor"
  ],
  "Atezolizumab": [
    "Atezolizumab"
  ],
  "Bevacizumab": [
    "Bevacizumab"
  ],
  "Capivasertib": [
    "Capivasertib",
    "capivasertib",
    "1143532-39-1",
    "AZD5363",
    "AZD-5363",
    "AZD 5363",
    "Truqap",
    "4-Amino-N-[(1s)-1-(4-Chlorophenyl)-3-Hydroxypropyl]-1-(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)piperidine-4-Carboxamide",
    "WFR23M21IE",
    "DTXSID40150710",
    "4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide",
    "capivasertibum",
    "4-Amino-N-((1S)-1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide",
    "RefChem:573743",
    "DTXCID4073201",
    "(S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE",
    "MFCD22628785",
    "4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-",
    "4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxy-propyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide",
    "UNII-WFR23M21IE",
    "CHEMBL2325741",
    "C21H25ClN6O2",
    "cc-638",
    "Capivasertib?",
    "(S)-4-Amino-N-[1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide",
    "4-PIPERIDINECARBOXAMIDE, 4-AMINO-N-((1S)-1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-",
    "Truqap (TN)",
    "Capivasertib (JAN/USAN)",
    "CAPIVASERTIB [INN]",
    "CAPIVASERTIB [JAN]",
    "CAPIVASERTIB [USAN]",
    "Capivasertib (AZD5363)",
    "4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide",
    "MLS006011179",
    "CAPIVASERTIB [WHO-DD]",
    "SCHEMBL390243",
    "GTPL7709",
    "orb1307109",
    "SCHEMBL29357463",
    "SCHEMBL29557103",
    "AZC5363",
    "EX-A285",
    "CHEBI:229222",
    "JDUBGYFRJFOXQC-KRWDZBQOSA-N",
    "US10654855, Example 9",
    "BDBM443385",
    "AZD5363?",
    "NSC764039",
    "NSC782347",
    "NSC799347",
    "s8019",
    "AKOS027323693",
    "CCG-268989",
    "CS-1284",
    "DB12218",
    "FA29493",
    "NSC-764039",
    "NSC-782347",
    "NSC-799347",
    "NCGC00345795-01",
    "NCGC00345795-03",
    "NCGC00345795-04",
    "NCGC00345795-08",
    "AC-32685",
    "BP-43630",
    "HY-15431",
    "SMR004702948",
    "SY018928",
    "DB-290280",
    "NS00072563",
    "SW220158-1",
    "D11371",
    "BRD-K99023089-001-03-7",
    "Q27074756",
    "0XZ",
    "4-AMINO-N-((1S)-1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1- (1H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE",
    "ALTERNATIVE ROUTE 1: (S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE"
  ],
  "Dostarlimab": [
    "Dostarlimab"
  ],
  "Elacestrant": [
    "Elacestrant",
    "722533-56-4",
    "RAD1901",
    "RAD-1901",
    "ORSERDU",
    "ER-306323",
    "elacestrantum",
    "FM6A2627A8",
    "DTXSID901045846",
    "(2R)-2-(2-(Ethyl-((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxy-phenyl)tetralin-6-ol",
    "(6R)-6-{2-[ethyl({4-[2-(ethylamino)ethyl]phenyl}methyl)amino]-4-methoxyphenyl}-5,6,7,8-tetrahydronaphthalen-2-ol",
    "2-Naphthalenol, 6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-, (6R)-",
    "(2R)-2-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxy-phenyl]tetralin-6-ol",
    "(6R)-6-(2-(Ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol",
    "RefChem:57007",
    "SERD/SERM RAD1901",
    "DTXCID401527776",
    "Elacestrant [INN]",
    "Elacestrant [USAN]",
    "MFCD30532693",
    "(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol",
    "(R)-6-(2-(Ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol",
    "(6R)-6-(2-(Ethyl((4-(2- (ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)- 5,6,7,8-tetrahydronaphthalen-2-ol",
    "(R)-6-[2-[Ethyl[4-[2-(ethylamino)ethyl]benzyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol",
    "Elacestrant (USAN/INN)",
    "Elacestrant [USAN:INN]",
    "ELACESTRANT [WHO-DD]",
    "SCHEMBL229431",
    "UNII-FM6A2627A8",
    "orb1308827",
    "CHEMBL4297509",
    "SCHEMBL29359701",
    "GTPL12339",
    "CHEBI:229213",
    "BDBM349630",
    "C30H38N2O2",
    "GLXC-26208",
    "EX-A5070",
    "RAD 1901",
    "US10208011, Compound RAD-",
    "?RAD-1901",
    "NSC854010",
    "WHO 10247",
    "XH1617",
    "AKOS032946378",
    "CS-6306",
    "DB06374",
    "NSC-854010",
    "AC-37208",
    "DA-63145",
    "ER306323",
    "HY-19822",
    "MS-28398",
    "SY357698",
    "D11671",
    "G15928",
    "Q27278069",
    "(6R)-6-[2-(ethyl{4-[2-(ethylamino)ethyl]benzyl}amino)-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol",
    "(6R)-6-[2-[ethyl[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5, 6,7,8-tetrahydro-2-Naphthalenol",
    "I0V"
  ],
  "Entrectinib": [
    "Entrectinib",
    "1108743-60-7",
    "Rozlytrek",
    "RXDX-101",
    "NMS-E628",
    "entrectinibum",
    "L5ORF0AN1I",
    "RXDX 101",
    "N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide",
    "DTXSID101026450",
    "Benzamide, N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-((tetrahydro-2H-pyran-4-yl)amino)-",
    "N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",
    "N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",
    "N-{5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide",
    "Benzamide, N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]-",
    "RXDX101",
    "N-(5-((3,5-Difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((oxan-4-yl)amino)benzamide",
    "N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide",
    "RefChem:58006",
    "L01XE56",
    "DTXCID101510637",
    "Entrectinib (RXDX-101)",
    "Entrectinib(rxdx-101)",
    "N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide",
    "MFCD28129099",
    "N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]benzamide",
    "N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydropyran-4-ylamino)benzamide",
    "Entrectinib [INN]",
    "UNII-L5ORF0AN1I",
    "Entrectinib [USAN:INN]",
    "C31H34F2N6O2",
    "Rozlytrek (TN)",
    "N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",
    "N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",
    "YMX",
    "Entrectinib, 95%",
    "RG 6268",
    "Entrectinib (Standard)",
    "Kinome_2659",
    "ENTRECTINIB [MI]",
    "ENTRECTINIB [JAN]",
    "Entrectinib; NMS-E628",
    "ENTRECTINIB [USAN]",
    "ENTRECTINIB [WHO-DD]",
    "Entrectinib (RXDX-101)?",
    "Entrectinib (JAN/USAN/INN)",
    "GTPL8290",
    "orb1303916",
    "SCHEMBL3512601",
    "CHEMBL1983268",
    "SCHEMBL29358922",
    "SCHEMBL29394152",
    "NMS-E 628",
    "ENTRECTINIB [ORANGE BOOK]",
    "CHEBI:195558",
    "HAYYBYPASCDWEQ-UHFFFAOYSA-N",
    "NMS-E628;RXDX-101",
    "HMS3886H21",
    "HMS5086A05",
    "EX-A2261",
    "HY-12678R",
    "NSC774769",
    "NSC800095",
    "RG6268",
    "s7998",
    "AKOS030632786",
    "CCG-270048",
    "DB11986",
    "NSC-774769",
    "NSC-800095",
    "RG-6268",
    "SB17194",
    "NCGC00484067-01",
    "NCGC00484067-02",
    "NCGC00484067-03",
    "AC-31286",
    "AS-75092",
    "BP-43651",
    "DA-47850",
    "HY-12678",
    "NS00072566",
    "D10926",
    "EN300-7376549",
    "BRD-K39009484-001-01-4",
    "Q25323953",
    "N-[5-(3,5-Difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide",
    "N-[5-[[3,5-bis(fluoranyl)phenyl]methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide",
    "N-{5-[(3,5-difluorophenyl)methyl]-3H-indazol-3-ylidene}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide"
  ],
  "Everolimus": [
    "Everolimus",
    "Afinitor",
    "Certican",
    "Zortress",
    "RAD001",
    "159351-69-6",
    "SDZ-RAD",
    "42-O-(2-Hydroxyethyl)rapamycin",
    "Votubia",
    "40-O-(2-hydroxyethyl)-rapamycin",
    "Afinitor Disperz",
    "SDZ RAD",
    "RAD-001",
    "everolimusum",
    "CHEBI:68478",
    "9HW64Q8G6G",
    "DTXSID0040599",
    "XIENCE V",
    "RAD 001",
    "RAD 666",
    "RAD-666",
    "Rapamycin, 42-O-(2-hydroxyethyl)-",
    "DTXCID8020599",
    "NSC733504",
    "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
    "(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",
    "(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",
    "42-O-(2-Hydroxy)ethyl rapamycin",
    "Everolimus tablets",
    "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
    "(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",
    "(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-((2R)-1-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)propan-2-yl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido(2,1-c)(1,4)oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",
    "TORPENZ",
    "RefChem:56904",
    "RAD, SDZ",
    "L01XE10",
    "L04AA18",
    "001, RAD",
    "40-O-(2-Hydroxyethyl)rapamycin",
    "RAD",
    "Everolimus (INN)",
    "NCGC00167512-01",
    "Everolimus (RAD001)",
    "EVEROLIMUS [INN]",
    "Everolimus (~90% pure)",
    "C53H83NO14",
    "MFCD00929329",
    "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",
    "Everolimus [USAN]",
    "Everolimus?",
    "EVE - Everolimus",
    "Everolimus (Standard)",
    "EVEROLIMUS [MI]",
    "EVEROLIMUS [JAN]",
    "EVEROLIMUS [VANDF]",
    "EVEROLIMUS [MART.]",
    "EVEROLIMUS [USP-RS]",
    "EVEROLIMUS [WHO-DD]",
    "UNII-9HW64Q8G6G",
    "EVEROLIMUS [EMA EPAR]",
    "Everolimus [USAN:INN:BAN]",
    "NVP-RAD-001",
    "Everolimus, analytical standard",
    "GTPL5889",
    "orb1307455",
    "RAD-001C",
    "CHEMBL1908360",
    "EVEROLIMUS [ORANGE BOOK]",
    "HSDB 8255",
    "EVEROLIMUS [EP MONOGRAPH]",
    "Everolimus; RAD001; SDZ-RAD",
    "42-O-(2-Hydroxyethyl)-rapamycin",
    "EX-A2057",
    "Tox21_112510",
    "BDBM50088378",
    "Everolimus (RAD-001, SDZ-RAD)",
    "HY-10218R",
    "AKOS015850977",
    "CS-0064",
    "DB01590",
    "FE23209",
    "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
    "AS-16971",
    "HY-10218",
    "CAS-159351-69-6",
    "351E696",
    "42-O-(2-Hydroxyethyl)rapamycin;RAD-001;SDZRAD",
    "Q421052",
    "BRD-K13514097-001-01-2",
    "BRD-K13514097-001-05-3",
    "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",
    "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",
    "dihydroxy-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-dimethoxy-hexamethyl-[?]pentone"
  ],
  "Exemestane": [
    "Exemestane",
    "EXEMESTANE",
    "107868-30-4",
    "Aromasin",
    "6-Methyleneandrosta-1,4-diene-3,17-dione",
    "Exemestano",
    "Exemestanum",
    "FCE-24304",
    "Androsta-1,4-diene-3,17-dione, 6-methylene-",
    "FCE24304",
    "PNU-155971",
    "DTXSID5023037",
    "NY22HMQ4BX",
    "CHEBI:4953",
    "NSC713563",
    "NSC-758907",
    "DTXCID003037",
    "(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione",
    "examestane",
    "(1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-diene-5,14-dione",
    "(1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,14-dione",
    "(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta(a)phenanthrene-3,17-dione",
    "RefChem:57964",
    "L02BG06",
    "Fce 24304",
    "Exemestanum [INN-Latin]",
    "Exemestano [INN-Spanish]",
    "6-Methylene-androsta-1,4-diene-3,17-dione",
    "C20H24O2",
    "(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione",
    "Exemestane (Standard)",
    "Aromasine",
    "MFCD00866994",
    "Aromasil",
    "(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione",
    "Exemestane [USAN:INN:BAN]",
    "Nikidess",
    "(8alpha,10alpha,13alpha)-6-Methylideneandrosta-1,4-Diene-3,17-Dione",
    "Aromasin (TN)",
    "SMR000466314",
    "CAS-107868-30-4",
    "HSDB 7463",
    "Curator_000009",
    "UNII-NY22HMQ4BX",
    "Exemestane (JAN/USP/INN)",
    "CCRIS 9351",
    "NCGC00095289-01",
    "Androsta-1,4-diene-3,17-dione, 6-methylene-; 6-Methyleneandrosta-1,4-diene-3,17-dione; Aromasil; Aromasin; Exemestane; FCE 24304",
    "Exemestane [INN]",
    "Exemestane; aromasin",
    "Exemestane, Aromasin",
    "PNU 155971",
    "EXEMESTANE [MI]",
    "EXEMESTANE [JAN]",
    "EXEMESTANE [HSDB]",
    "EXEMESTANE [USAN]",
    "EXEMESTANE [VANDF]",
    "EXEMESTANE [MART.]",
    "SCHEMBL6215",
    "Aromasin (Pharmacia Upjohn)",
    "EXEMESTANE [USP-RS]",
    "EXEMESTANE [WHO-DD]",
    "Exemestane(FCE 24304)",
    "MLS000759419",
    "MLS001424062",
    "orb315348",
    "Exemestane(FCE 24304)?",
    "GTPL7073",
    "6-Methylenandrosta-1,17-dione",
    "CHEMBL1200374",
    "EXEMESTANE [ORANGE BOOK]",
    "Exemestane, >=98% (HPLC)",
    "EXEMESTANE [EP MONOGRAPH]",
    "EXEMESTANE [USP MONOGRAPH]",
    "GLXC-06573",
    "HMS2051J04",
    "HMS3713H12",
    "MSK10960",
    "Tox21_111499",
    "BDBM50398447",
    "HY-13632R",
    "s1196",
    "AKOS015840113",
    "AKOS015895161",
    "Tox21_111499_1",
    "AC-2171",
    "CCG-100995",
    "CS-1766",
    "DB00990",
    "FM23211",
    "KS-5136",
    "NC00245",
    "NSC 758907",
    "NSC-713563",
    "NCGC00271596-03",
    "(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione",
    "6-methylenandrost-1,4-dien-3,17-dione",
    "AS-31053",
    "CPD000466314",
    "HY-13632",
    "6-Methylen-androst-1,4-diene-3,17-dione",
    "CS-0694867",
    "E0941",
    "NS00000304",
    "C08162",
    "D00963",
    "AB00639936-06",
    "AB00639936-08",
    "AB00639936-09",
    "AB00639936-10",
    "AB00639936_11",
    "868E304",
    "Q418819",
    "SR-01000759393",
    "6-Methylenandrosta-1,4-diene-3,17-dione;Aromasin",
    "SR-01000759393-4",
    "BRD-K33425534-001-12-5",
    "Exemestane, European Pharmacopoeia (EP) Reference Standard",
    "Exemestane, United States Pharmacopeia (USP) Reference Standard",
    "Exemestane, Pharmaceutical Secondary Standard; Certified Reference Material",
    "Exemestane for system suitability, European Pharmacopoeia (EP) Reference Standard",
    "EXM"
  ],
  "Fulvestrant": [
    "Fulvestrant",
    "129453-61-8",
    "Faslodex",
    "ICI 182,780",
    "Ici 182780",
    "ICI-182780",
    "ZD-9238",
    "fulvestrantum",
    "ZD9238",
    "DTXSID4022369",
    "(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",
    "ICI182780",
    "Faslodex(ICI 182,780)",
    "Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7alpha,17beta)-",
    "CHEBI:31638",
    "22X328QOC4",
    "NSC-759879",
    "7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol",
    "DTXCID202369",
    "NSC719276",
    "Estra-1,3,5(10)-triene-3,17-diol, 7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-, (7alpha,17beta)-",
    "(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol",
    "(1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta(a)phenanthrene-1,7-diol",
    "(1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-diol",
    "(7alpha,17beta)-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1(10),2,4-triene-3,17-diol",
    "(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthrene-3,17-diol",
    "ZM182780",
    "RefChem:57293",
    "7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol",
    "L02BA03",
    "(1S,9R,11S,14S,15S)-15-methyl-9-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)tetracyclo(8.7.0.02,7.011,15)heptadeca-2,4,6-triene-5,14-diol",
    "642-998-6",
    "7a-(9-((4,4,5,5,5,-Pentafluoropentyl)sulphinyl)nonyl)-estra-1,3,5(10)-triene-3,17b-diol",
    "ZM 182780",
    "ZM-182780",
    "Fulvestrant (Standard)",
    "C32H47F5O3S",
    "CHEMBL1358",
    "Fulvestrant S enantiomer",
    "(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "Fulvestrant (Faslodex)",
    "Fulvestrant [USAN]",
    "Fulvestrant R enantiomer",
    "MFCD00903953",
    "(7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "Faslodex (TN)",
    "(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol",
    "7alpha-[9[(4,4,5,5,5-Pentafluropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17 beta diol",
    "CAS-129453-61-8",
    "ZD 182780",
    "1316849-17-8",
    "Fluvestrant",
    "UNII-22X328QOC4",
    "Fulvestrant?",
    "CCRIS 8741",
    "HSDB 7658",
    "NCGC00024964-02",
    "1807900-80-6",
    "Fulvestrant [USAN:USP:INN:BAN]",
    "ZD-182780",
    "FULVESTRANT [MI]",
    "FULVESTRANT [INN]",
    "FULVESTRANT [JAN]",
    "FULVESTRANT [VANDF]",
    "SCHEMBL8209",
    "FULVESTRANT [MART.]",
    "BIDD:PXR0136",
    "FULVESTRANT [USP-RS]",
    "FULVESTRANT [WHO-DD]",
    "MLS006010187",
    "BIDD:ER0348",
    "Fulvestrant (JAN/USP/INN)",
    "FULVESTRANT [EMA EPAR]",
    "Fulvestrant, >98% (HPLC)",
    "GTPL1015",
    "orb1306347",
    "Fulvestrant - Bio-X trade mark",
    "SCHEMBL29353866",
    "EX-A959",
    "FULVESTRANT [ORANGE BOOK]",
    "ICI 182,780 (Fulvestrant)",
    "MSK8055",
    "FULVESTRANT [EP MONOGRAPH]",
    "FULVESTRANT [USP IMPURITY]",
    "GLXC-03001",
    "HMS2090N22",
    "HMS3260G10",
    "HMS3712A06",
    "FULVESTRANT [USP MONOGRAPH]",
    "(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "Tox21_110939",
    "Tox21_202604",
    "Tox21_303656",
    "Tox21_500114",
    "BDBM50169743",
    "HB2501",
    "HY-13636R",
    "MSK8055-100M",
    "AKOS015895669",
    "Tox21_110939_1",
    "AC-4693",
    "CCG-220082",
    "CCG-221418",
    "CS-1267",
    "DB00947",
    "FF23615",
    "LP00114",
    "NSC 759879",
    "NSC-719276",
    "SDCCGSBI-0633685.P001",
    "ZD 9238",
    "ICI 182 780",
    "ICI 182,789",
    "NCGC00164789-02",
    "NCGC00164789-04",
    "NCGC00257357-01",
    "NCGC00260152-01",
    "NCGC00260799-01",
    "NCGC00386134-10",
    "(7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",
    "AS-13024",
    "BI167222",
    "DA-63628",
    "HY-13636",
    "SMR001456109",
    "CS-0694849",
    "F1144",
    "Fulvestrant Solution in Methanol, 100ug/mL",
    "NS00004276",
    "S1191",
    "Fulvestrant, Vetec(TM) reagent grade, >98%",
    "D01161",
    "EN300-120628",
    "AB01273957-01",
    "AB01273957-02",
    "AB01273957-03",
    "AB01273957_04",
    "453F618",
    "Q5508491",
    "BRD-A85667082-001-12-7",
    "Fulvestrant, European Pharmacopoeia (EP) Reference Standard",
    "Fulvestrant, United States Pharmacopeia (USP) Reference Standard",
    "Fulvestrant for system suitability, European Pharmacopoeia (EP) Reference Standard",
    "(13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "(7a,17b)-7-[9-[(4,4,5,5,5pentafluoropentyl)Sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol",
    "(7a,17b)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;Faslodex;Fulvestrant;ZD 182780",
    "(7a,17b)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;Faslodex;Fulvestrant;ZD 182780;ICI 182780",
    "(7R,13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentyldihydrosulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "(7R,8R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "(7R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",
    "13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "13-Methyl-7-[9-(4,5,5,5-pentafluoropentylsulfinyl)nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",
    "7.ALPHA.-(9-(4,4,5,5,5-PENTAFLUOROPENTYLSULPHINYL)NONYL)ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL",
    "7alpha-[9-(4,4,5,5,5-pentafluoro-pentylsulfinyl)nonyl]estra-1,3,5(10)-triene-3,17beta-diol",
    "7alpha-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17beta-diol",
    "ESTRA-1,3,5(10)-TRIENE-3,17-DIOL, 7-(9-((4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL)NONYL)-, (7.ALPHA.,17.BETA.)-",
    "Estra-1,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7.alpha.,17.beta.)-"
  ],
  "Lapatinib": [
    "Lapatinib",
    "231277-92-2",
    "GW572016",
    "GW 572016",
    "GSK 572016",
    "GW-572016",
    "DTXSID7046675",
    "N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine",
    "CHEBI:49603",
    "0VUA21238F",
    "GSK-572016",
    "GW-572016X",
    "n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine",
    "DTXCID5026675",
    "4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-",
    "N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine",
    "GSK572016",
    "lapatinibum",
    "N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-methanesulfonylethyl)amino)methyl)furan-2-yl)quinazolin-4-amine",
    "RefChem:798502",
    "L01XE07",
    "GW2016",
    "GW 2016",
    "GW-282974X",
    "878-720-7",
    "N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl)-2-furyl)-4-quinazolinamine",
    "NSC727989",
    "Tykerb",
    "Lapatinib [INN]",
    "MFCD09264194",
    "Lapatinib base",
    "C29H26ClFN4O4S",
    "Lapatinib (INN)",
    "Lapatinib free base",
    "N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine",
    "N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine",
    "Lapatinib (free base)",
    "231277-92-2 (free base)",
    "FMM",
    "N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE",
    "CHEMBL554",
    "1210608-87-9",
    "NSC745750",
    "s2111",
    "N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine",
    "NCGC00167507-01",
    "GW 282974X",
    "913989-15-8",
    "N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine",
    "N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine",
    "CAS-231277-92-2",
    "GW-2016",
    "Lapatinib [INN:BAN]",
    "UNII-0VUA21238F",
    "Lapatinib?",
    "HSDB 8209",
    "1xkk",
    "N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine",
    "N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine",
    "Lapatinib ditosylate?",
    "Lapatinib (Standard)",
    "Lapatinib, Free base",
    "nchembio866-comp20",
    "Kinome_3684",
    "Kinome_3685",
    "LAPATINIB [MI]",
    "LAPATINIB [VANDF]",
    "LAPATINIB [WHO-DD]",
    "SCHEMBL8100",
    "Lapatinib (GW572016)",
    "LAPATINIB [EMA EPAR]",
    "BDBM5445",
    "cid_208908",
    "GTPL5692",
    "orb1310962",
    "SCHEMBL29351024",
    "SCHEMBL29464189",
    "EX-A402",
    "BCFGMOOMADDAQU-UHFFFAOYSA-N",
    "GLXC-06463",
    "HMS2089H10",
    "HMS3244N06",
    "HMS3244N10",
    "HMS3244N14",
    "HMS3744K11",
    "HMS5080G12",
    "Tykerb (TN) (Glaxo Smith Kline)",
    "Lapatinib base - Bio-X trade mark",
    "Tox21_112505",
    "HY-50898R",
    "NSC800780",
    "AKOS005145766",
    "Tox21_112505_1",
    "AC-1314",
    "CCG-270133",
    "DB01259",
    "FC12433",
    "NSC-745750",
    "NSC-800780",
    "SB16918",
    "SDCCGSBI-0634417.P003",
    "NCGC00167507-02",
    "NCGC00167507-03",
    "NCGC00167507-04",
    "NCGC00167507-09",
    "AS-14065",
    "BC164610",
    "BP-43661",
    "HY-50898",
    "N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine",
    "N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine",
    "L0360",
    "NS00003012",
    "SW199101-5",
    "D08108",
    "EN300-117254",
    "AB01273965-01",
    "AB01273965-02",
    "AB01273965-03",
    "AB01273965_04",
    "AB01273965_05",
    "277L922",
    "Q420323",
    "SR-05000001472-1",
    "BRD-K19687926-001-01-7",
    "BRD-K19687926-001-04-1",
    "BRD-K19687926-001-10-8",
    "BRD-K19687926-379-02-5",
    "BRD-K19687926-379-07-4",
    "1092929-10-6",
    "GW572016;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine",
    "N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5-({[2-(methanesulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine",
    "N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine",
    "N-{3-chloro-4-[(3-fluoro-benzyl)oxy]phenyl}-6-[5-({2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine",
    "N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine",
    "N-{3-Chloro-4[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine"
  ],
  "Larotrectinib": [
    "Larotrectinib",
    "1223403-58-4",
    "LOXO-101",
    "ARRY-470",
    "LOXO 101",
    "LOXO101",
    "BAY2757556",
    "BAY-2757556",
    "ARRY 470",
    "PF9462I9HX",
    "1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-",
    "(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide",
    "DTXSID101020707",
    "1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-",
    "larotrectinibum",
    "ARRY470",
    "(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide",
    "(3S)-N-{5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidine-1-carboxamide",
    "RefChem:57159",
    "L01XE53",
    "DTXCID001493220",
    "(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-1-pyrrolidinecarboxamide",
    "(3S)-N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide",
    "3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide",
    "826-190-2",
    "(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide",
    "LarotrectinibFor",
    "Vitrakvi",
    "MFCD28902192",
    "Larotrectinib (LOXO-101 free base)",
    "C21H22F2N6O2",
    "(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-pyrrolidine-1-carboxamide",
    "Larotrectinib [INN]",
    "Larotrectinib (Standard)",
    "LAROTRECTINIB [MI]",
    "ARRY-470; larotrectinib",
    "Larotrectinib (USAN/INN)",
    "Larotrectinib [USAN:INN]",
    "LAROTRECTINIB [USAN]",
    "UNII-PF9462I9HX",
    "LAROTRECTINIB [WHO-DD]",
    "GTPL8909",
    "orb1301362",
    "SCHEMBL2241012",
    "CHEMBL3889654",
    "SCHEMBL29420193",
    "NYNZQNWKBKUAII-KBXCAEBGSA-N",
    "BDBM136597",
    "EX-A1981",
    "HY-12866R",
    "NSC785570",
    "NSC801004",
    "s5860",
    "AKOS027338709",
    "example 14 [US8865698 B2]",
    "CS-5722",
    "DB14723",
    "NSC-785570",
    "NSC-801004",
    "AC-33660",
    "AS-35231",
    "BP-43662",
    "FD145150",
    "HY-12866",
    "NS00133777",
    "D11137",
    "EN300-7411765",
    "US8865698, 14",
    "BRD-K36574127-001-01-3",
    "Q27081513",
    "(3S)-N-(5-((2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN- 1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE- 1-CARBOXAMIDE",
    "(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide",
    "(S)-N-(5 -((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide",
    "(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin -1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide",
    "(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide",
    "(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3 yl)-3-hydroxypyrrolidine-1-carboxamide",
    "LOXO 101;(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide;ARR  Y 470"
  ],
  "Letrozole": [
    "Letrozole",
    "letrozole",
    "112809-51-5",
    "Femara",
    "Letrozol",
    "CGS 20267",
    "CGS-20267",
    "Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-",
    "4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile",
    "4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile",
    "DTXSID4023202",
    "CGS20267",
    "NSC-759652",
    "7LKK855W8I",
    "CHEBI:6413",
    "4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE",
    "DTXCID503202",
    "NSC719345",
    "KISQALI FEMARA CO-PACK COMPONENT LETROZOLE",
    "letrozolum",
    "4-((4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl)benzonitrile",
    "4-((4-cyanophenyl)(1H-1,2,4-triazol-1-yl)methyl)benzonitrile",
    "Letrozole Tablets",
    "4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)",
    "RefChem:55460",
    "L02BG04",
    "4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile",
    "675-034-8",
    "4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile",
    "C17H11N5",
    "Femera",
    "4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile",
    "4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile",
    "1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole",
    "MFCD00866241",
    "CHEMBL1444",
    "4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile",
    "NCGC00016973-01",
    "Letoval",
    "CAS-112809-51-5",
    "SMR000466343",
    "Femara (TN)",
    "LETRAZOLE",
    "HSDB 7461",
    "SR-01000759382",
    "Letrozole (JAN/USP/INN)",
    "UNII-7LKK855W8I",
    "4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile",
    "CCRIS 8822",
    "Letrozole?",
    "FEM-345",
    "Femara, Letrozole",
    "Letrozole [USAN:USP:INN:BAN]",
    "Letrozole (Standard)",
    "LETROZOLE [INN]",
    "LETROZOLE [JAN]",
    "LETROZOLE [MI]",
    "LETROZOLE [HSDB]",
    "LETROZOLE [USAN]",
    "Prestwick0_001025",
    "Prestwick1_001025",
    "Prestwick2_001025",
    "Prestwick3_001025",
    "Femara (TN) (Novartis)",
    "LETROZOLE [MART.]",
    "LETROZOLE [USP-RS]",
    "LETROZOLE [WHO-DD]",
    "SCHEMBL4331",
    "1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole",
    "BIDD:PXR0130",
    "BSPBio_001209",
    "MLS000759455",
    "MLS001424038",
    "MLS002584991",
    "MLS006010040",
    "BIDD:GT0015",
    "Letrozole - Bio-X trade mark",
    "SPBio_003070",
    "BPBio1_001331",
    "GTPL5209",
    "orb1308084",
    "LETROZOLE [EP IMPURITY]",
    "LETROZOLE [ORANGE BOOK]",
    "LETROZOLE [EP MONOGRAPH]",
    "Letrozole, >=98% (HPLC)",
    "BDBM13061",
    "EX-A965",
    "LETROZOLE [USP MONOGRAPH]",
    "GLXC-05072",
    "HMS1571M11",
    "HMS2051E08",
    "HMS2089L22",
    "HMS2098M11",
    "HMS2233C23",
    "HMS3369E11",
    "HMS3393E08",
    "HMS3651K05",
    "HMS3715M11",
    "HMS5079O19",
    "Pharmakon1600-01502354",
    "IVB71296",
    "MSK10362",
    "Tox21_110719",
    "Tox21_303572",
    "HY-14248R",
    "NSC759652",
    "s1235",
    "STL451047",
    "AKOS005145822",
    "AB07525",
    "AC-1193",
    "CCG-100849",
    "CS-1776",
    "DB01006",
    "FL24873",
    "KS-1269",
    "NC00099",
    "NSC 759652",
    "NSC-719345",
    "NCGC00016973-02",
    "NCGC00016973-03",
    "NCGC00016973-06",
    "NCGC00257460-01",
    "BL164620",
    "HY-14248",
    "1-Bis(4-cyanophenyl)methyl-1,2,4-triazole",
    "4,2,4-Triazol-1-ylmethylene)dibenzonitrile",
    "AB00514009",
    "L0248",
    "NS00000663",
    "SW197294-4",
    "A25380",
    "C08163",
    "D00964",
    "EN300-264820",
    "AB00514009-05",
    "AB00514009-07",
    "AB00514009-08",
    "AB00514009-09",
    "AB00514009_10",
    "AB00514009_11",
    "809L515",
    "F036495",
    "Q194974",
    "W-60273",
    "4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile",
    "SR-01000759382-4",
    "SR-01000759382-5",
    "BRD-K88789588-001-03-2",
    "BRD-K88789588-001-14-9",
    "4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile",
    "F2173-0288",
    "Z1741968261",
    "4,4'-((1H-1,2,4-Triazol-1-yl)-methylene)dibenzonitrile",
    "4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzonitrile]",
    "Letrozole, European Pharmacopoeia (EP) Reference Standard",
    "Letrozole, United States Pharmacopeia (USP) Reference Standard",
    "4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE",
    "Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material"
  ],
  "Margetuximab": [
    "Margetuximab"
  ],
  "Neratinib": [
    "Neratinib",
    "698387-09-6",
    "HKI-272",
    "HKI 272",
    "JJH94R3PWB",
    "PB-272",
    "(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",
    "CDP-820",
    "PB 272",
    "HKI272",
    "CHEBI:61397",
    "DTXSID70220132",
    "(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
    "(2e)-n-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
    "2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-",
    "N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide",
    "neratinibum",
    "(2E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
    "(2E)-N-[4-({3-chloro-4-[(pyridin-2-yl)methoxy]phenyl}amino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",
    "RefChem:56993",
    "DTXCID70142623",
    "L10XE45",
    "Neratinib (HKI-272)",
    "Nerlynx",
    "MFCD09752958",
    "(E)-N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
    "CHEMBL180022",
    "(E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
    "698387-09-6 (free base)",
    "WAY-179272",
    "(2E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide",
    "(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",
    "C30H29ClN6O3",
    "Neratinib [USAN]",
    "Neratinib [USAN:INN]",
    "UNII-JJH94R3PWB",
    "Neratinib (Standard)",
    "NERATINIB [INN]",
    "NERATINIB [MI]",
    "Neratinib (USAN/INN)",
    "NERATINIB [MART.]",
    "NERATINIB [WHO-DD]",
    "Neratinib (HKI-272)?",
    "SCHEMBL571762",
    "Neratinib - Bio-X trade mark",
    "GTPL5686",
    "orb1305687",
    "SCHEMBL29376313",
    "SCHEMBL29394766",
    "EX-A062",
    "HMS5087D17",
    "BDBM50161957",
    "HY-32721R",
    "NSC757439",
    "NSC800803",
    "s2150",
    "WAY-179272-B",
    "AKOS005146340",
    "AKOS025149637",
    "CCG-270036",
    "DB11828",
    "FN65101",
    "NSC-757439",
    "NSC-800803",
    "SDCCGSBI-0654392.P001",
    "NCGC00241101-01",
    "NCGC00241101-03",
    "NCGC00241101-08",
    "NCGC00241101-09",
    "(E)-N-[4-[3-chloro-4-(2-pyridylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide",
    "AC-25073",
    "AS-16279",
    "BN164645",
    "BP-44032",
    "HY-32721",
    "N1062",
    "NS00069565",
    "D08950",
    "EN300-7386009",
    "387N096",
    "Q6995920",
    "BRD-K85606544-001-01-8",
    "BRD-K85606544-001-09-1",
    "(E)-4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide",
    "4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide",
    "N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
    "N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)butanamide"
  ],
  "Olaparib": [
    "Olaparib",
    "763113-22-0",
    "AZD2281",
    "Lynparza",
    "KU-0059436",
    "AZD-2281",
    "AZD 2281",
    "KU-59436",
    "WOH1JD9AR8",
    "Olaparibum",
    "AZ2281",
    "NSC-747856",
    "4-[[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one",
    "CHEBI:83766",
    "AZ-2281",
    "KEYLYNK-010 COMPONENT OLAPARIB",
    "DTXSID60917988",
    "4-(3-{[4-(Cyclopropylcarbonyl)piperazin-1-Yl]carbonyl}-4-Fluorobenzyl)phthalazin-1(2h)-One",
    "4-[(3-{[4-(Cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]phthalazin-1(2H)-one",
    "4-{[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one",
    "4-(3-((4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",
    "4-((3-((4-(CYCLOPROPYLCARBONYL)PIPERAZIN-1-YL)CARBONYL)-4-FLUOROPHENYL)METHYL)PHTHALAZIN-1(2H)-ONE",
    "4-((3-(4-(cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorophenyl)methyl)-2H-phthalazin-1-one",
    "4-((3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl)methyl)-1,2-dihydrophthalazin-1-one",
    "4-((3-{(4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl}-4-fluorophenyl)methyl)phthalazin-1(2H)-one",
    "RefChem:57006",
    "PARP inhibitor AZD2281",
    "L01XX46",
    "DTXCID001346944",
    "1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine",
    "4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one",
    "MFCD13185161",
    "Olaparib (AZD2281, Ku-0059436)",
    "OLAPARIB cpd",
    "Olaparib (AZD-2281)",
    "Olaparib [USAN:INN]",
    "C24H23FN4O3",
    "UNII-WOH1JD9AR8",
    "4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one",
    "KU59436",
    "Olaparib (DISCONTINUED)",
    "4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one",
    "4-[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorobenzyl]phthalazin-1(2H)-one",
    "Olaparib [INN]",
    "Olaparib (AZD2281; Ku-0059436)",
    "Olaparib (AZD2281)",
    "Olaparib, KU-0059436",
    "AZD221",
    "937799-91-2",
    "Lynparza (TN)",
    "09L",
    "4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; AZD 2281; KU 0059436; KU 59436; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine;",
    "Olaparib (Standard)",
    "AZD2281(olaparib)",
    "KU 59436",
    "OLAPARIB [USAN]",
    "OLAPARIB [JAN]",
    "OLAPARIB [MI]",
    "OLAPARIB [VANDF]",
    "OLAPARIB [MART.]",
    "OLAPARIB [WHO-DD]",
    "Olaparib (JAN/USAN/INN)",
    "AZD-2281 (Olaparib)?",
    "MLS006010185",
    "Olaparib - Bio-X trade mark",
    "SCHEMBL426568",
    "OLAPARIB [ORANGE BOOK]",
    "CHEMBL521686",
    "GTPL7519",
    "orb1304620",
    "SCHEMBL29352148",
    "SCHEMBL29392087",
    "BDBM27566",
    "EX-A002",
    "FDLYAMZZIXQODN-UHFFFAOYSA-N",
    "GLXC-02796",
    "HMS3295I09",
    "HMS3426C03",
    "HMS3654G13",
    "HMS3746K07",
    "HMS3870H03",
    "HMS5079O07",
    "HMS6019J08",
    "763113-22-0, Lynparza,",
    "HY-10162R",
    "NSC747856",
    "NSC753686",
    "s1060",
    "AKOS005145764",
    "AC-7939",
    "CCG-264799",
    "CS-0075",
    "DB09074",
    "EX-7210",
    "FO33122",
    "NSC 747856",
    "NSC-753686",
    "SB14617",
    "SS-4573",
    "AZD2281,Olaparib, KU-0059436",
    "NCGC00238451-01",
    "NCGC00238451-02",
    "NCGC00238451-08",
    "NCGC00238451-09",
    "NCGC00238451-11",
    "1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-",
    "4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone",
    "BO164169",
    "BP-43641",
    "HY-10162",
    "SMR004701291",
    "SY040527",
    "OLAPARIB COMPONENT OF KEYLYNK-010",
    "NS00072449",
    "SW218142-2",
    "D09730",
    "EN300-7542225",
    "F043403",
    "Q7083106",
    "BRD-K02113016-001-08-9",
    "BRD-K02113016-001-09-7",
    "BRD-K02113016-001-15-4",
    "BRD-K02113016-001-19-6",
    "Z2227698469",
    "4-(3-{[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl}-4-fluorobenzyl)-1(2H)-phthalazinone",
    "(2H)-Phthalazinone, 4-((3-((4-(cyclopropylcarbonyl)-1-piperazinyl)carbonyl)-4-fluorophenyl)methyl)-",
    "1021843-02-6",
    "4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one",
    "PIPERAZINE, 1-(CYCLOPROPYLCARBONYL)-4-(5-((3,4-DIHYDRO-4-OXO-1-PHTHALAZINYL)METHYL)-2-FLUOROBENZOYL)-"
  ],
  "Palbociclib": [
    "Palbociclib",
    "571190-30-2",
    "PD-0332991",
    "Ibrance",
    "PD0332991",
    "PD 0332991",
    "6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one",
    "G9ZF61LE7G",
    "CHEBI:85993",
    "PD 332991",
    "6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one",
    "6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one",
    "DTXSID40972590",
    "6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one",
    "Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-",
    "Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-",
    "palbociclibum",
    "6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-((5-(PIPERAZIN-1-YL)PYRIDIN-2-YL)AMINO)-8H-PYRIDO(2,3-D)PYRIMIDIN-7-ONE",
    "6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido(2,3-d)pyrimidin-7(8H)-one",
    "6-acetyl-8-cyclopentyl-5-methyl-2-((5-piperazin-1-ylpyridin-2-yl)amino)pyrido(6,5-d)pyrimidin-7-one",
    "6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[6,5-d]pyrimidin-7-one",
    "RefChem:6097",
    "DTXCID80207212",
    "L01XE33",
    "PD 991",
    "Palbociclib free base",
    "MFCD11840850",
    "UNII-G9ZF61LE7G",
    "571190-30-2 (free base)",
    "6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",
    "Palbociclib(PD0332991)",
    "C24H29N7O2",
    "LQQ",
    "2euf",
    "Palbociclib [USAN]",
    "PD-332991",
    "Palbociclib [USAN:INN]",
    "Palbociclib?",
    "Ibrance (TN)",
    "Kinome_3823",
    "Kinome_3824",
    "Palbociclib (Standard)",
    "PALBOCICLIB [MI]",
    "6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8h-pyrido[2,3-d]pyrimidin-7-one hydrochloride",
    "PALBOCICLIB [INN]",
    "PALBOCICLIB [JAN]",
    "Palbociclib (JAN/USAN)",
    "PALBOCICLIB [WHO-DD]",
    "6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one",
    "SCHEMBL462630",
    "BDBM6309",
    "CHEMBL189963",
    "GTPL7380",
    "orb1307454",
    "Palbociclib - Bio-X trade mark",
    "SCHEMBL29362383",
    "SCHEMBL29379411",
    "SCHEMBL30584526",
    "EX-A408",
    "PALBOCICLIB [ORANGE BOOK]",
    "2euf; PD 0332991",
    "AHJRHEGDXFFMBM-UHFFFAOYSA-N",
    "HMS3265M09",
    "HMS3265M10",
    "HMS3265N09",
    "HMS3265N10",
    "HMS3744G13",
    "HMS5087D18",
    "HY-50767R",
    "NSC758247",
    "NSC772256",
    "NSC800815",
    "s4482",
    "AKOS022205241",
    "DB09073",
    "FA65120",
    "NSC-758247",
    "NSC-772256",
    "NSC-800815",
    "SB40426",
    "SDCCGSBI-0646936.P001",
    "Pyrido-[2,3-d]-pyrimidin-7-one 43",
    "NCGC00263129-01",
    "NCGC00263129-08",
    "NCGC00263129-21",
    "NCGC00263129-22",
    "6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridyl)amino]pyrido[2,3-d]pyrimidin-7-one",
    "6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one",
    "AC-25485",
    "AS-17016",
    "BP-43645",
    "BP-44037",
    "BP166224",
    "HY-50767",
    "SY026143",
    "571190-30-2(DMSO)",
    "A8153",
    "NS00069617",
    "D10372",
    "190P302",
    "EN300-18531248",
    "F794410",
    "PD 0332991,PD0332991",
    "BRD-K51313569-001-01-1",
    "BRD-K51313569-001-07-8",
    "BRD-K51313569-003-03-3",
    "P-0332991",
    "Q15269707",
    "Z2216894329",
    "6-acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one",
    "6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one",
    "6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one",
    "6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one",
    "6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)-pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one",
    "6-Acetyl-8-cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one;PD 0332991;Ibrance",
    "8-cyclopentyl-6-acetyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one"
  ],
  "Pembrolizumab": [
    "Pembrolizumab"
  ],
  "Pertuzumab": [
    "Pertuzumab"
  ],
  "Ribociclib": [
    "Ribociclib",
    "1211441-98-3",
    "LEE011",
    "LEE-011",
    "7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide",
    "LEE011A",
    "TK8ERE8P56",
    "7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide",
    "LEE-011A",
    "DTXSID201021027",
    "ribociclibum",
    "7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo(2,3-d)pyrimidine-6-carboxamide",
    "RefChem:55976",
    "L01XE42",
    "DTXCID701506068",
    "807-111-0",
    "Ribociclib (LEE011)",
    "Kisqali",
    "LEE 011",
    "UNII-TK8ERE8P56",
    "MFCD27976795",
    "7-Cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide",
    "7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide",
    "C23H30N8O",
    "7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo [2,3-d]pyrimidine-6-carboxylic acid dimethylamide",
    "7-Cyclopentyl-N,N-dimethyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide",
    "Ribociclib [INN]",
    "Ribociclib, LEE011",
    "Ribociclib [USAN:INN]",
    "6ZZ",
    "7H-Pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-; 7-Cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide; Kisqali; LEE 011; LEE 011A; Ribociclib",
    "Ribociclib (Standard)",
    "RIBOCICLIB [MI]",
    "Ribociclib (USAN/INN)",
    "RIBOCICLIB [USAN]",
    "Ribociclib (LEE011)?",
    "NVP-LEE011",
    "RIBOCICLIB [WHO-DD]",
    "SCHEMBL302310",
    "GTPL7383",
    "orb1300987",
    "CHEMBL3545110",
    "SCHEMBL29384231",
    "SCHEMBL29385337",
    "SCHEMBL29912679",
    "EX-A304",
    "CHEBI:230905",
    "RHXHGRAEPCAFML-UHFFFAOYSA-N",
    "BDBM148264",
    "HMS3653N03",
    "HMS3673I19",
    "HMS3748M05",
    "HMS5085P14",
    "example 74 [US8962630]",
    "HY-15777R",
    "NSC778909",
    "NSC794613",
    "NSC800867",
    "s7440",
    "AKOS025404915",
    "AKOS032949987",
    "CCG-269070",
    "CS-1750",
    "DB11730",
    "NSC-778909",
    "NSC-794613",
    "NSC-800867",
    "SB18480",
    "NCGC00386317-10",
    "NCGC00386317-11",
    "AC-30029",
    "AS-10159",
    "BP-44045",
    "DA-35904",
    "FR106414",
    "HY-15777",
    "NS00072964",
    "SW220101-1",
    "D10883",
    "EN300-7409093",
    "US8962630, 74",
    "BRD-K36788280-001-01-2",
    "BRD-K36788280-001-03-8",
    "BRD-K36788280-001-04-6",
    "Q27088552",
    "7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide",
    "7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-yl-2-pyridyl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide",
    "7H-Pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-"
  ],
  "Sacituzumab govitecan": [
    "Sacituzumab govitecan",
    "hRS7-SN38",
    "1491917-83-9",
    "IMMU-132",
    "M9BYU8XDQ6",
    "DTXSID401335985",
    "Trodelvy",
    "SacituzumabGovitecan",
    "sacituzumabum govitecanum",
    "RefChem:58300",
    "Sacituzumab govitecan-hziy",
    "hRS7SN38",
    "RS7-SN38",
    "DTXCID601766057",
    "hRS7-SN38 Antibody Drug Conjugate",
    "HRS7-SN38-ANTIBODY-DRUG-CONJUGATE",
    "Sacituzumab govitecan [USAN]",
    "UNII-M9BYU8XDQ6",
    "hRS 7SN38",
    "IMMU 132",
    "1796566-95-4",
    "1535963-91-7",
    "Satralizumab linker",
    "sacituzumab-govitecan",
    "DA64T2C2IO",
    "CYSTEINYL CL2A-SN-38",
    "orb2702946",
    "SCHEMBL29407082",
    "SN-38 CYSTEINYL CONJUGATE",
    "EX-A4354",
    "GOVITECAN CYSTEINYL CONJUGATE",
    "DA-77702",
    "F82944"
  ],
  "Selpercatinib": [
    "Selpercatinib",
    "2152628-33-4",
    "Retevmo",
    "CEGM9YBNGD",
    "LY3527723",
    "Ret inhibitor loxo-292",
    "6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile",
    "DTXSID901026442",
    "WHO 10967",
    "6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyridin-3-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile",
    "LY-3527723",
    "6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitrile",
    "6-(2-hydroxy-2-methylpropoxy)-4-(6-{6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl}pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile",
    "Pyrazolo(1,5-a)pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxy-3-pyridinyl)methyl)-3,6-diazabicyclo(3.1.1)hept-3-yl)-3-pyridinyl)-",
    "selpercatinibum",
    "RefChem:58689",
    "RET Kinase Inhibitor LOXO-292",
    "DTXCID001510634",
    "6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitril",
    "843-660-2",
    "Loxo-292",
    "LOXO292",
    "6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile",
    "Selpercatinib (LOXO-292)",
    "Selpercatinib [INN]",
    "Selpercatinib [USAN]",
    "Serpercatinib",
    "Retevmo (TN)",
    "MFCD31814089",
    "UNII-CEGM9YBNGD",
    "Selpercatinib (Standard)",
    "LOXO-292; Selpercatinib",
    "Selpercatinib [USAN:INN]",
    "Selpercatinib(LOXO-292)",
    "Selpercatinib(LOXO-292)?",
    "orb1299110",
    "CHEMBL4559134",
    "SCHEMBL20071478",
    "SCHEMBL29349774",
    "SCHEMBL29362388",
    "Selpercatinib (JAN/USAN/INN)",
    "GTPL10318",
    "BDBM296429",
    "GLXC-21357",
    "GLXC-21860",
    "HMS5086P13",
    "EX-A2859",
    "NSC818434",
    "s8781",
    "ZB1574",
    "US10112942, Example 163",
    "US10112942, Example 166",
    "US10112942, Example 183",
    "AKOS037649115",
    "HY-114370R",
    "NSC-818434",
    "AC-31588",
    "BP-44049",
    "BS-16622",
    "DA-57785",
    "Selpercatinib (LOXO-292, ARRY-192)",
    "example 163 [WO2018071447A1]",
    "HY-114370",
    "CS-0084279",
    "D11713",
    "D77980",
    "EN300-27032767",
    "6-(2-hydroxy-2-methyl-propoxy)-4-[6-[6-[(6-methoxy-3-pyridyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridyl]pyrazolo[1,5-a]pyridine-3-carbonitrile",
    "Selpercatinib; Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]-; 6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hep"
  ],
  "Talazoparib": [
    "Talazoparib",
    "1207456-01-6",
    "BMN-673",
    "BMN 673",
    "BMN673",
    "9QHX048FRV",
    "DTXSID001025928",
    "3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)-",
    "PF-06944076",
    "talazoparibum",
    "RefChem:57302",
    "L01XX60",
    "DTXCID901510174",
    "(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(1-methyl-1H-1,2,4-triazol-5-yl)-2,3,10-triazatricyclo(7.3.1.0^(5,13))trideca-1,5,7,9(13)-tetraen-4-one",
    "815-271-8",
    "LT-673",
    "Talazoparib (BMN 673)",
    "(8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one",
    "MFCD22666357",
    "C19H14F2N6O",
    "(8s,9r)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1h-1,2,4-Triazol-5-Yl)-2,7,8,9-Tetrahydro-3h-Pyrido[4,3,2-De]phthalazin-3-One",
    "(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8-tetraen-4-one",
    "(8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one",
    "(8S,9R)-BMN 673",
    "Talazoparib [USAN:INN]",
    "UNII-9QHX048FRV",
    "4pjt",
    "2YQ",
    "TALAZOPARIB [MI]",
    "Talazoparib(BMN-673)",
    "TALAZOPARIB [INN]",
    "Talazoparib (USAN/INN)",
    "TALAZOPARIB [USAN]",
    "Talazoparib (BMN-673)",
    "Talazoparib(BMN-673)?",
    "TALAZOPARIB [WHO-DD]",
    "GTPL8313",
    "orb1300934",
    "SCHEMBL2299348",
    "CHEMBL3137320",
    "SCHEMBL29351841",
    "BMN673,BMN-673",
    "CHEBI:231344",
    "HWGQMRYQVZSGDQ-HZPDHXFCSA-N",
    "GLXC-06076",
    "EX-A1356",
    "BDBM50084621",
    "NSC767125",
    "AKOS027250735",
    "AKOS040758983",
    "CS-0937",
    "DB11760",
    "NSC-767125",
    "NCGC00351600-09",
    "NCGC00390231-01",
    "AC-30927",
    "AS-57491",
    "BP-44054",
    "FF103545",
    "HY-16106",
    "LT 00673",
    "SY387326",
    "NS00072968",
    "S7048",
    "SW219655-1",
    "D10732",
    "EN300-20176329",
    "BRD-K95142244-001-01-5",
    "Q25100990",
    "Q27453411",
    "(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(1-methyl-1H-1,2,4-triazol-5-yl)-2,3,10-triazatricyclo[7.3.1.0,5,13]trideca-1,5,7,9(13)-tetraen-4-one",
    "Talazoparib; (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one"
  ],
  "Tamoxifen": [
    "Tamoxifen",
    "tamoxifen",
    "10540-29-1",
    "trans-Tamoxifen",
    "Crisafeno",
    "Tamoxifene",
    "Diemon",
    "Tamoxifeno",
    "Citofen",
    "Istubol",
    "Oncomox",
    "Retaxim",
    "Tamizam",
    "Tamoxen",
    "Valodex",
    "Tamoxifenum",
    "Novaldex",
    "Mammaton",
    "Tamoplex",
    "Apo-Tamox",
    "(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine",
    "1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene",
    "1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene",
    "2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine",
    "ICI 47699",
    "ICI-47699",
    "NSC-727681",
    "DTXSID1034187",
    "CHEBI:41774",
    "094ZI81Y45",
    "(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine",
    "DTXCID9014187",
    "Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-",
    "Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-",
    "(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine",
    "(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-n,n-dimethylethanamine",
    "Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-",
    "2-(4-((Z)-1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine",
    "(2-(4-((1Z)-1,2-diphenylbut-1-en-1-yl)phenoxy)ethyl)dimethylamine",
    "2-(4-((Z)-1,2-di(phenyl)but-1-enyl)phenoxy)-N,N-dimethylethanamine",
    "2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine",
    "ICI-46,474",
    "RefChem:6281",
    "L02BA01",
    "ICI46474",
    "ICI47699",
    "ICI46,474",
    "1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene",
    "234-118-0",
    "Caditam",
    "Nolvadex",
    "Tamoxifene [INN-French]",
    "Tamoxifenum [INN-Latin]",
    "Tamoxifeno [INN-Spanish]",
    "Tamoxifen (INN)",
    "Tamoxifen (Standard)",
    "CHEMBL83",
    "MFCD00010454",
    "2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine",
    "(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene",
    "(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE",
    "Tamoxifen (Z)",
    "TAMOXIFEN [INN]",
    "(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine",
    "2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine",
    "Tamoxifen [INN:BAN]",
    "Tamoxifen (1.0 mg/mL in Methanol)",
    "[3H]tamoxifen",
    "[3H]-tamoxifen",
    "Tamoplex (TN)",
    "SMR000059172",
    "CAS-10540-29-1",
    "TRANS FORM OF TAMOXIFEN",
    "CCRIS 3275",
    "HSDB 6782",
    "EINECS 234-118-0",
    ",citrate",
    "Tamoxifen?",
    "Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-",
    "UNII-094ZI81Y45",
    "Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)-",
    "ETHANAMINE, 2-(4-((1Z)-1,2-DIPHENYL-1-BUTEN-1-YL)PHENOXY)-N,N-DIMETHYL-",
    "Tamoxifen, 7",
    "trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine",
    "(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)",
    "Tocris-0999",
    "1ya4",
    "Tamoxifen, >=99%",
    "TAMOXIFEN [MI]",
    "TAMOXIFEN [HSDB]",
    "TAMOXIFEN [IARC]",
    "Prestwick2_000146",
    "Prestwick3_000146",
    "Spectrum5_001417",
    "Spectrum5_002043",
    "TAMOXIFEN [VANDF]",
    "UPCMLD-DP027",
    "EC 234-118-0",
    "SCHEMBL4084",
    "TAMOXIFEN [WHO-DD]",
    "BIDD:PXR0003",
    "Lopac0_001203",
    "BSPBio_000252",
    "BSPBio_001150",
    "BSPBio_001982",
    "MLS001332535",
    "MLS001332536",
    "BIDD:ER0008",
    "BIDD:GT0009",
    "Tamoxifen, analytical standard",
    "Tamoxifen - Bio-X trade mark",
    "BPBio1_000278",
    "GTPL1016",
    "GTPL5384",
    "orb2281178",
    "BDBM20607",
    "cid_2733526",
    "cMAP_000044",
    "GLXC-06537",
    "HMS1362J11",
    "HMS1792J11",
    "HMS1990J11",
    "HMS2090N08",
    "HMS2232C12",
    "HMS3261D09",
    "HMS3403J11",
    "HMS3411P04",
    "HY-13757AR",
    "MSK10364",
    "Tox21_201243",
    "Tox21_300539",
    "Tox21_500494",
    "(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine",
    "1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene",
    "HB0601",
    "HY-13757A",
    "NSC727681",
    "AKOS022143035",
    "CCG-205277",
    "DB00675",
    "FD12063",
    "FT27994",
    "KS-1472",
    "LP00494",
    "SDCCGSBI-0051170.P007",
    "ICI47699;Z-Tamoxifen;trans-Tamoxifen",
    "IDI1_000258",
    "IDI1_002170",
    "QTL1_000079",
    "NCGC00024928-01",
    "NCGC00024928-03",
    "NCGC00024928-04",
    "NCGC00024928-05",
    "NCGC00024928-07",
    "NCGC00024928-08",
    "NCGC00024928-09",
    "NCGC00024928-10",
    "NCGC00024928-11",
    "NCGC00024928-12",
    "NCGC00024928-13",
    "NCGC00024928-14",
    "NCGC00024928-15",
    "NCGC00024928-16",
    "NCGC00024928-17",
    "NCGC00024928-18",
    "NCGC00024928-19",
    "NCGC00024928-39",
    "NCGC00024928-40",
    "NCGC00254455-01",
    "NCGC00258795-01",
    "NCGC00261179-01",
    "AC-35768",
    "BT164438",
    "SBI-0051170.P004",
    "CS-0694848",
    "NS00010353",
    "C07108",
    "D08559",
    "AB00053547-16",
    "AB00053547-17",
    "AB00053547-18",
    "AB00053547_19",
    "AB00053547_20",
    "EN300-1273241",
    "540T291",
    "A801229",
    "L024126",
    "Q412178",
    "BRD-K93754473-001-02-9",
    "BRD-K93754473-048-04-6",
    "BRD-K93754473-048-05-3",
    "BRD-K93754473-048-10-3",
    "BRD-K93754473-048-18-6",
    "BRD-K93754473-048-19-4",
    "BRD-K93754473-048-20-2",
    "BRD-K93754473-048-21-0",
    "Tamoxifen, certified reference material, TraceCERT(R)",
    "Z2527624834",
    "(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine",
    "(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine;ICI 47699;Mammaton",
    "(Z)-2-4-(1,2-Diphenyl-1-butenyl)phenoxy-N,N-dimethylethanamine;ICI 47699;Mammaton"
  ],
  "Toremifene": [
    "Toremifene",
    "toremifene",
    "Acapodene",
    "Farestone",
    "89778-26-7",
    "Toremifeno",
    "Toremifenum",
    "Chlortamoxifen",
    "Toremiphene",
    "GTx-006",
    "7NFE54O27T",
    "CHEBI:9635",
    "J33.157K",
    "(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine",
    "DTXSID3023689",
    "Ethanamine, 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-",
    "(2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine",
    "ETHANAMINE, 2-(4-((1Z)-4-CHLORO-1,2-DIPHENYL-1-BUTEN-1-YL)PHENOXY)-N,N-DIMETHYL-",
    "(2-(4-((1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy)ethyl)dimethylamine",
    "2-(4-((Z)-4-chloro-1,2-di(phenyl)but-1-enyl)phenoxy)-N,N-dimethylethanamine",
    "2-[4-[(Z)-4-chloro-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine",
    "RefChem:57433",
    "DTXCID503689",
    "L02BA02",
    "(Z)-4-Chloro-1,2-diphenyl-1(4-(2-(N,N-dimethylamino)ethoxy)phenyl)-1-butene",
    "618-298-1",
    "(E)-Toremifene",
    "Toremifene (INN)",
    "MFCD00801070",
    "Z-Toremifene",
    "2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine",
    "Toremifenum [Latin]",
    "Toremifeno [Spanish]",
    "89778-26-7 (free base)",
    "Ethanamine, 2-(4-((1Z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-",
    "89778-29-0",
    "TOREMIFENE [INN]",
    "Toremifene Base",
    "Toremifene [INN:BAN]",
    "2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine",
    "GTx 006",
    "Estrimex",
    "UNII-7NFE54O27T",
    "CCRIS 8745",
    "2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC)",
    "TOREMIFENE [MI]",
    "TOREMIFENE [IARC]",
    "TOREMIFENE [VANDF]",
    "SCHEMBL7465",
    "CHEMBL1655",
    "TOREMIFENE [WHO-DD]",
    "BIDD:PXR0202",
    "BIDD:ER0222",
    "BIDD:GT0211",
    "TOREMIFENE [EMA EPAR]",
    "GTPL4325",
    "BDBM58492",
    "cid_3005572",
    "HY-B0005A",
    "HMS2090B22",
    "HMS3714P06",
    "MSK10575",
    "DL-519",
    "STK626445",
    "AKOS005559276",
    "AC-1751",
    "CCG-220952",
    "CS-1268",
    "DB00539",
    "2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine",
    "2-[4-[(Z)-4-chloro-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine",
    "MRF-0000351",
    "NCGC00160530-02",
    "NCGC00160530-13",
    "SBI-0206902.P001",
    "NS00002900",
    "78T267",
    "C08166",
    "D08620",
    "D95973",
    "AB00698360-07",
    "AB00698360-09",
    "AB00698360-10",
    "AB00698360_11",
    "AB00698360_12",
    "EN300-22411559",
    "Q3993743",
    "SR-01000763502-5",
    "BRD-K51350053-048-06-6",
    "BRD-K51350053-048-15-7",
    "BRD-K51350053-048-16-5",
    "BRD-K51350053-048-17-3",
    "2-[4-[(Z)-4-chloro-1,2-diphenyl-but-1-enyl]phenoxy]ethyl-dimethyl-amine;citric acid",
    "2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethan-1-amine",
    "2-[4-[(Z)-4-chloranyl-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine;2-oxidanylpropane-1,2,3-tricarboxylic acid",
    "275360-73-1",
    "T0R"
  ],
  "Trastuzumab": [
    "Trastuzumab"
  ],
  "Trastuzumab deruxtecan": [
    "Trastuzumab deruxtecan"
  ],
  "Trastuzumab emtansine": [
    "Trastuzumab emtansine",
    "Ado-trastuzuMab-eMtansine cas nr",
    "1018448-65-1",
    "C47H64ClN5O13S",
    "MFCD28138412",
    "[(1S,2R,3S,5R,6S,16Z,18Z,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2S)-2-[3-[1-[(4-carbamoylcyclohexyl)methyl]-2,5-dioxo-pyrrolidin-3-yl]sulfanylpropanoyl-methyl-amino]propanoate",
    "[(1S,2R,3S,5R,6S,16Z,18Z,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2S)-2-[3-[1-[(4-carbamoylcyclohexyl)methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoyl-methylamino]propanoate"
  ],
  "Tucatinib": [
    "Tucatinib",
    "Irbinitinib",
    "937263-43-9",
    "Tukysa",
    "ONT-380",
    "N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine",
    "234248D0HH",
    "MK-7119",
    "DTXSID601027958",
    "4,6-Quinazolinediamine, N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)-",
    "N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine",
    "N6-(4,5-dihydro-4,4-dmethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-A)pyridin-7-Yloxy)phenyl)-4,6-quinazolinediamine",
    "tucatinibum",
    "4,6-QuinazolinediaMine, N6-(4,5-dihydro-4,4-diMethyl-2-oxazolyl)-N4-[3-Methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-",
    "N6-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine",
    "N6-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-N4-(3-methyl-4-{[1,2,4]triazolo[1,5-a]pyridin-7-yloxy}phenyl)quinazoline-4,6-diamine",
    "N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine",
    "N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)-4,6-quinazolinediamine",
    "RefChem:58754",
    "DTXCID801513525",
    "6-DIAMINE",
    "N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine",
    "Irbinitinib; ARRY-380; ONT-380",
    "Tucatinib [INN]",
    "6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine",
    "Arry 380",
    "UNII-234248D0HH",
    "ONT 380",
    "C26H24N8O2",
    "MFCD22380467",
    "Tukysa (TN)",
    "Tucatinib; Irbinitinib",
    "ONT-380;Tucatinib",
    "TUCATINIB [MI]",
    "Tucatinib (USAN/INN)",
    "Tucatinib [USAN:INN]",
    "TUCATINIB [USAN]",
    "Irbinitinib(ARRY-380)",
    "Irbinitinib; ARRY-380",
    "TUCATINIB [WHO-DD]",
    "GTPL9922",
    "orb1305592",
    "SCHEMBL1193050",
    "TUCATINIB [ORANGE BOOK]",
    "CHEMBL3989868",
    "SCHEMBL29351516",
    "SCHEMBL29351934",
    "SCHEMBL29475609",
    "SCHEMBL29653672",
    "SDEAXTCZPQIFQM-UHFFFAOYSA-N",
    "BDBM471617",
    "HMS5086M09",
    "EX-A1031",
    "Tucatinib (Irbinitinib, ONT-380)",
    "NSC764581",
    "NSC799335",
    "s8362",
    "ARRY-380 (ONT-380)",
    "Tucatinib (Irbinitinib,ARRY-380)?",
    "AKOS026750449",
    "CCG-264747",
    "CS-3906",
    "DB11652",
    "NSC-764581",
    "NSC-799335",
    "SB17126",
    "US10822334, Compound ONT380",
    "NCGC00482879-02",
    "AC-33037",
    "AS-56109",
    "BP-40974",
    "BT177688",
    "HY-16069",
    "Example 11 [WO2007059257A2]",
    "DB-130430",
    "NS00072928",
    "D11141",
    "EN300-24438049",
    "BRD-K26026438-001-01-0",
    "Q25100690",
    "ARRY-380; 4,6-Quinazolinediamine, N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-; N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine;",
    "N6-(4,4-dimethyl-5H-oxazol-2-yl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine"
  ]
}